Article
Tacrolimus Population Pharmacokinetics and Multiple CYP3A5 Genotypes in Black and White Renal Transplant Recipients.
Journal of clinical pharmacology - 1 Sept 2018
Campagne Olivia, Mager Donald E, Brazeau Daniel, Venuto Rocco C, Tornatore Kathleen M
Abstract excerpt
Tacrolimus exhibits inter-patient pharmacokinetic variability attributed to CYP3A5 isoenzymes and the efflux transporter, P-glycoprotein. Most black renal transplant recipients require higher tacrolimus doses compared to whites to achieve similar troughs when race-adjusted recommendations are used. An established guideline provides tacrolimus genotype dosing recommendations based on CYP3A5*1(W/T) and loss of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
